Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2021

01-12-2021 | Naloxone | Review

The effect of opioids on gastrointestinal function in the ICU

Authors: Yun Yan, Yu Chen, Xijing Zhang

Published in: Critical Care | Issue 1/2021

Login to get access

Abstract

Gastrointestinal (GI) dysfunction is common in the critical care setting and is highly associated with clinical outcomes. Opioids increase the risk for GI dysfunction and are frequently prescribed to reduce pain in critically ill patients. However, the role of opioids in GI function remains uncertain in the ICU. This review aims to describe the effect of opioids on GI motility, their potential risk of increasing infection and the treatment of GI dysmotility with opioid antagonists in the ICU setting.
Literature
1.
Rombeau JL, Takala J. Summary of round table conference: gut dysfunction in critical illness. Intensive Care Med. 1997;23:476–9.PubMed
2.
3.
Drewes AM, Munkholm P, Simrén M, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group. Scand J Pain. 2016;11:111–22.PubMed
4.
Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22:128–41.PubMed
5.
Reintam Blaser A, Malbrain MLNG, Starkopf J, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012;38:384–94.PubMedPubMedCentral
6.
Li H, Zhang D, Wang Y, et al. Association between acute gastrointestinal injury grading system and disease severity and prognosis in critically ill patients: a multicenter, prospective, observational study in China. J Crit Care. 2016;36:24–8.PubMed
7.
Ding L, Chen H-Y, Wang J-Y, et al. Severity of acute gastrointestinal injury grade is a good predictor of mortality in critically ill patients with acute pancreatitis. World J Gastroenterol. 2020;26:514–23.PubMedPubMedCentral
8.
Reintam Blaser A, Starkopf J, Malbrain MLNG. Abdominal signs and symptoms in intensive care patients. Anaesthesiol Intensive Ther. 2015;47:379–87.PubMed
9.
Reintam A, Parm P, Kitus R, et al. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand. 2009;53:318–24.PubMed
10.
Wilmer A, Tack J, Frans E, et al. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology. 1999;116:1293–9.PubMed
11.
Mostafa SM, Bhandari S, Ritchie G, et al. Constipation and its implications in the critically ill patient. Br J Anaesth. 2003;91:815–9.PubMed
12.
Reintam A, Parm P, Kitus R, et al. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12:R90.PubMedPubMedCentral
13.
Reintam A, Parm P, Redlich U, et al. Gastrointestinal failure in intensive care: a retrospective clinical study in three different intensive care units in Germany and Estonia. BMC Gastroenterol. 2006;6:19.PubMedPubMedCentral
14.
Pyati S, Gan TJ. Perioperative pain management. CNS Drugs. 2007;21:185–211.PubMed
15.
Sigakis MJG, Bittner EA. Ten myths and misconceptions regarding pain management in the ICU. Crit Care Med. 2015;43:2468–78.PubMed
16.
Donohue JM, Kennedy JN, Seymour CW, et al. Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use: a cohort study. Ann Intern Med. 2019;171:81–90.PubMedPubMedCentral
17.
Richards-Belle A, Canter RR, Power GS, et al. National survey and point prevalence study of sedation practice in UK critical care. Crit Care. 2016;20:355.PubMedPubMedCentral
18.
Friedman A, Nabong L. Opioids: pharmacology, physiology, and clinical implications in pain medicine. Phys Med Rehabil Clin N Am. 2020;31:289–303.PubMed
19.
Patel D, Callaway J, Vaezi M. Opioid-induced foregut dysfunction. Am J Gastroenterol. 2019;114:1716–25.PubMed
20.
Akbarali HI, Dewey WL. Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link? Nat Rev Gastroenterol Hepatol. 2019;16:323–4.PubMedPubMedCentral
21.
Rossi M, Casale G, Badiali D, et al. Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert board. Support Care Cancer. 2019;27:4083–90.PubMedPubMedCentral
22.
Fruhwald S, Holzer P, Metzler H. Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med. 2007;33:36–44.PubMed
23.
DeHaven-Hudkins DL, DeHaven RN, Little PJ, et al. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. Pharmacol Ther. 2008;117:162–87.PubMed
24.
Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004;16(Suppl 2):17–28.PubMed
25.
26.
Sternini C, Patierno S, Selmer I-S, et al. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil. 2004;16(Suppl 2):3–16.PubMed
27.
Sobczak M, Sałaga M, Storr MA, et al. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol. 2014;49:24–45.PubMed
28.
Galligan JJ, Sternini C. Insights into the role of opioid receptors in the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2017;239:363–78.PubMedPubMedCentral
29.
Poole DP, Pelayo J-C, Scherrer G, et al. Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice. Gastroenterology. 2011;141:982-991.e18.PubMed
30.
Mitolo-Chieppa D, Natale L, Marasciulo FL, et al. Involvement of kappa-opioid receptors in peripheral response to nerve stimulation in kappa-opioid receptor knockout mice. Auton Autacoid Pharmacol. 2002;22:233–9.PubMed
31.
Albert-Vartanian A, Boyd MR, Hall AL, et al. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther. 2016;41:371–82.PubMed
32.
Heyland DK, Tougas G, King D, et al. Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med. 1996;22:1339–44.PubMed
33.
Nind G, Chen W-H, Protheroe R, et al. Mechanisms of gastroesophageal reflux in critically ill mechanically ventilated patients. Gastroenterology. 2005;128:600–6.PubMed
34.
Heinonen T, Ferrie S, Ferguson C. Gut function in the intensive care unit: what is “normal”? Aust Crit Care. 2020;33:151–4.PubMed
35.
Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med. 2001;29:1955–61.PubMed
36.
Bosscha K, Nieuwenhuijs VB, Vos A, et al. Gastrointestinal motility and gastric tube feeding in mechanically ventilated patients. Crit Care Med. 1998;26:1510–7.PubMed
37.
Nguyen NQ, Chapman MJ, Fraser RJ, et al. The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness. Intensive Care Med. 2008;34:454–60.PubMed
38.
McArthur CJ, Gin T, McLaren IM, et al. Gastric emptying following brain injury: effects of choice of sedation and intracranial pressure. Intensive Care Med. 1995;21:573–6.PubMed
39.
40.
Webster LR. Opioid-induced constipation. Pain Med. 2015;16(Suppl 1):16–21.
41.
42.
Deane AM, Summers MJ, Zaknic AV, et al. Glucose absorption and small intestinal transit in critical illness. Crit Care Med. 2011;39:1282–8.PubMed
43.
van der Spoel JI, Schultz MJ, van der Voort PHJ, et al. Influence of severity of illness, medication and selective decontamination on defecation. Intensive Care Med. 2006;32:875–80.PubMed
44.
Launey Y, Painvin B, Roquilly A, et al. Factors associated with time to defecate and outcomes in critically ill patients: a prospective, multicentre, observational study. Anaesthesia. 2021;76:218–24.PubMed
45.
46.
Gacouin A, Camus C, Gros A, et al. Constipation in long-term ventilated patients: associated factors and impact on intensive care unit outcomes. Crit Care Med. 2010;38:1933–8.PubMed
47.
Fukuda S, Miyauchi T, Fujita M, et al. Risk factors for late defecation and its association with the outcomes of critically ill patients: a retrospective observational study. J Intensive Care. 2016;4:33.PubMedPubMedCentral
48.
Prat D, Messika J, Avenel A, et al. Constipation incidence and impact in medical critical care patients: importance of the definition criterion. Eur J Gastroenterol Hepatol. 2016;28:290–6.PubMed
49.
Shimizu K, Ogura H, Matsumoto N, et al. Interstitial cells of Cajal are diminished in critically ill patients: autopsy cases. Nutrition. 2020;70:110591.PubMed
50.
Alverdy JC, Krezalek MA. Collapse of the microbiome, emergence of the pathobiome, and the immunopathology of sepsis. Crit Care Med. 2017;45:337–47.PubMedPubMedCentral
51.
Banerjee S, Sindberg G, Wang F, et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9:1418–28.PubMedPubMedCentral
52.
Wang F, Meng J, Zhang L, et al. Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection. Gut Microbes. 2020;11:172–90.PubMed
53.
Meng J, Banerjee S, Li D, et al. Opioid exacerbation of gram-positive sepsis, induced by gut microbial modulation, is rescued by IL-17A neutralization. Sci Rep. 2015;5:10918.PubMedPubMedCentral
54.
Babrowski T, Holbrook C, Moss J, et al. Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration. Ann Surg. 2012;255:386–93.PubMed
55.
Wang F, Meng J, Zhang L, et al. Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model. Sci Rep. 2018;8:3596.PubMedPubMedCentral
56.
Shakhsheer BA, Versten LA, Luo JN, et al. Morphine promotes colonization of anastomotic tissues with collagenase: producing Enterococcus faecalis and causes leak. J Gastrointest Surg. 2016;20:1744–51.PubMed
57.
Asakura H, Kawamoto K, Igimi S, et al. Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol Immunol. 2006;50:543–7.PubMed
58.
Ma J, Wang J, Wan J, et al. Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect Immun. 2010;78:830–7.PubMed
59.
Hamilton LA, Behal ML. Altering routine intensive care unit practices to support commensalism. Nutr Clin Pract. 2020;35:433–41.PubMed
60.
Wiese AD, Griffin MR, Schaffner W, et al. Long-acting opioid use and the risk of serious infections: a retrospective cohort study. Clin Infect Dis. 2019;68:1862–9.PubMed
61.
Vincent C, Miller MA, Edens TJ, et al. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection. Microbiome. 2016;4:12.PubMedPubMedCentral
62.
Acharya C, Betrapally NS, Gillevet PM, et al. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45:319–31.PubMed
63.
Zhernakova A, Kurilshikov A, Bonder MJ, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352:565–9.PubMedPubMedCentral
64.
Budd K. Pain management: is opioid immunosuppression a clinical problem? Biomed Pharmacother. 2006;60:310–7.PubMed
65.
Glattard E, Welters ID, Lavaux T, et al. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS ONE. 2010;5:e8791.PubMedPubMedCentral
66.
Schwacha MG, McGwin G, Hutchinson CB, et al. The contribution of opiate analgesics to the development of infectious complications in burn patients. Am J Surg. 2006;192:82–6.PubMed
67.
Saini HS, Alvi Z, Singh B, et al. Methylnaltrexone and naloxone for opioid-induced constipation in the critical care setting. Cureus. 2020;12:e6829.PubMedPubMedCentral
68.
Schwenk ES, Grant AE, Torjman MC, et al. The efficacy of peripheral opioid antagonists in opioid-induced constipation and postoperative ileus: a systematic review of the literature. Reg Anesth Pain Med. 2017;42:767–77.PubMed
69.
Reintam Blaser A, Preiser J-C, Fruhwald S, et al. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020;24:224.PubMedPubMedCentral
70.
Pergolizzi JV Jr, Christo PJ, LeQuang JA, et al. The use of peripheral μ-opioid receptor antagonists (PAMORA) in the management of opioid-induced constipation: an update on their efficacy and safety. DDDT. 2020;14:1009–25.PubMed
71.
Yuan CS, Foss JF, Moss J. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. Eur J Pharmacol. 1995;276:107–11.PubMed
72.
Anselmi L, Huynh J, Vegezzi G, et al. Effects of methylnaltrexone on guinea pig gastrointestinal motility. Naunyn Schmiedebergs Arch Pharmacol. 2013;386:279–86.PubMedPubMedCentral
73.
Patel PB, Brett SJ, O’Callaghan D, et al. Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. Intensive Care Med. 2020;46:747–55.PubMedPubMedCentral
74.
Wasilewski A, Lesniak A, Bujalska-Zadrozny M, et al. The effect of opioid agonists and antagonists on gastrointestinal motility in mice selected for high and low swim stress-induced analgesia. Neurogastroenterol Motil. 2016;28:175–85.PubMed
75.
Greenwood-Van Meerveld B, Gardner CJ, Little PJ, et al. Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Neurogastroenterol Motil. 2004;16(Suppl 2):46–53.PubMed
76.
Meissner W, Dohrn B, Reinhart K. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia. Crit Care Med. 2003;31:776–80.PubMed
77.
Gibson CM, Pass SE. Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit. J Crit Care. 2014;29:803–7.PubMed
78.
Arpino PA, Thompson BT. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit. J Clin Pharm Ther. 2009;34:171–5.PubMed
79.
Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manag. 2002;23:48–53.
80.
Fukuda H, Suenaga K, Tsuchida D, et al. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats. Brain Res. 2006;1102:63–70.PubMed
81.
Merchan C, Altshuler D, Papadopoulos J. Methylnaltrexone versus naloxone for opioid-induced constipation in the medical intensive care unit. Ann Pharmacother. 2017;51:203–8.PubMed
82.
Berger MM, Bollmann MD, Revelly JP, et al. Progression rate of self-propelled feeding tubes in critically ill patients. Intensive Care Med. 2002;28:1768–74.PubMed
83.
Chapman MJ, Besanko LK, Burgstad CM, et al. Gastric emptying of a liquid nutrient meal in the critically ill: relationship between scintigraphic and carbon breath test measurement. Gut. 2011;60:1336–43.PubMed
84.
Nguyen T, Frenette A-J, Johanson C, et al. Impaired gastrointestinal transit and its associated morbidity in the intensive care unit. J Crit Care. 2013;28(537):e11–7.
85.
Sawh SB, Selvaraj IP, Danga A, et al. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients. Mayo Clin Proc. 2012;87:255–9.PubMedPubMedCentral
86.
87.
Massachusetts General Hospital. The effect of naloxegol on refractory constipation in the intensive care unit (narc-ICU). In: clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: https://​clinicaltrials.​gov/​ct2/​show/​NCT02705378?​
Metadata
Title
The effect of opioids on gastrointestinal function in the ICU
Authors
Yun Yan
Yu Chen
Xijing Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2021
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-021-03793-1

Other articles of this Issue 1/2021

Critical Care 1/2021 Go to the issue

Research

Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe

Research

Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis

Research

The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients

Research

Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs

Research

Effect of intra-arrest trans-nasal evaporative cooling in out-of-hospital cardiac arrest: a pooled individual participant data analysis

Research

Galectin-3 in septic acute kidney injury: a translational study